Avet Pharmaceuticals Inc. announced the immediate availability of Acyclovir Tablets in 400mg and 800mg strengths. This product is the AB rated generic equivalent to the brand Zovirax® and adds to Avet’s robust portfolio of generic oral solid products. According to IMS data for the twelve-months ended July 2013, the U.S. market for Acyclovir Tablets approximated $78 million.